M&A Deal Summary

Precision Cell Systems Acquires S2 Genomics

On September 17, 2025, Precision Cell Systems acquired life science company S2 Genomics from The BroadOak Fund

Acquisition Highlights
  • This is Precision Cell Systems’ 2nd transaction in the Life Science sector.
  • This is Precision Cell Systems’ 2nd transaction in the United States.
  • This is Precision Cell Systems’ 1st transaction in California.

M&A Deal Summary

Date 2025-09-17
Target S2 Genomics
Sector Life Science
Buyer(s) Precision Cell Systems
Sellers(s) The BroadOak Fund
Deal Type Add-on Acquisition

Target

S2 Genomics

Livermore, California, United States
S2 Genomics develops automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. S2 Genomics is based in Livermore, California.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Precision Cell Systems

Livermore, California, United States

Category Company
Founded 2025
Sector Life Science
DESCRIPTION

Precision Cell Systems is a cell analysis tools company that consolidates groundbreaking technologies to create sustainable businesses with clear paths to profitability. By integrating complementary workflow technologies and streamlining operations, PCS provides the infrastructure necessary to transform promising innovations into reliable, market-ready solutions for researchers and drug developers. Precision Cell Systems was formed in 2025 and is headquartered in Livermore, California.


DEAL STATS #
Overall 2 of 3
Sector: Life Science M&A 2 of 3
Type: Add-on Acquisition M&A Deals 1 of 2
State: California M&A 1 of 1
Country: United States M&A 2 of 3
Year: 2025 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-17 Orflo Technologies

Ketchum, Idaho, United States

Orflo Technologies is a supplier of cell analysis instruments, including flow cytometers and cell counters, consumables, and reagents. ORFLO’s two flagship products are the Moxi Go, a benchtop flow cytometer, and the Moxi Z, a cell counter. Orflo Technologies was founded in 2003 and is based in Ketchum, Idaho.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-10-01 BennuBio

Albuquerque, New Mexico, United States

BennuBio is a life science company that has developed an imaging flow cytometer for high-throughput analysis of 3D multicellular models, including spheroids, organoids, and stem cell aggregates. BennuBio was founded in 2018 and is based in Albuquerque, New Mexico.

Buy -

Seller(S) 1

DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


DEAL STATS #
Overall 8 of 8
Sector: Life Science M&A 7 of 7
Type: Add-on Acquisition M&A Deals 7 of 7
State: California M&A 3 of 3
Country: United States M&A 8 of 8
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-17 Precision Cell Systems

Livermore, California, United States

Precision Cell Systems is a cell analysis tools company that consolidates groundbreaking technologies to create sustainable businesses with clear paths to profitability. By integrating complementary workflow technologies and streamlining operations, PCS provides the infrastructure necessary to transform promising innovations into reliable, market-ready solutions for researchers and drug developers. Precision Cell Systems was formed in 2025 and is headquartered in Livermore, California.

Buy -